The University of Wisconsin–Madison was ranked 35th out of 437 public and private doctoral institutions, and 12th among public universities, in the 2024 edition of U.S. News & World Report’s best colleges rankings....
Leaders of the UW System and Wisconsin Technical College System are developing a new pathway transfer program for students pursuing degrees in science, technology, engineering and math....
BioForward Wisconsin is pleased to announce the recipients of the ninth annual Wisconsin Biohealth Awards, recognizing exceptional scientific and business accomplishments within the state’s thriving biohealth industry....
Agilent Technologies, Inc. and Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, today announced they have entered into a definitive agreement for the sale of Resolution Bioscience to Exact Sciences. ...
Researchers at the University of Wisconsin–Madison are taking part in a new collaboration built on open-science principles that will use machine learning to advance our knowledge of promising sources of magnetic fusion energy....
Discovery to Product (D2P) is pleased to share its Annual Impact Report. Learn how D2P makes a difference, providing mentoring, training and funding to UW–Madison innovators and startups and connecting campus and community ecosystems....
Exact Sciences Corp. today announced that the National Cancer Institute (NCI) has selected the company's testing laboratory in Phoenix, AZ to participate in the ComboMATCH clinical trials, one of the NCI-funded precision medicine initiatives....
In new research published recently in the journal Scientific Reports, Gandara and Drummond-Barbosa describe how chronic exposure to warm temperatures causes infertility in adult male Drosophila....
The University of Wisconsin–Madison has joined a statewide consortium of 15 public and private partners, mobilizing its experience and expertise as a collaborative powerhouse in bioscience and technology to help bolster Wisconsin’s leadership in personalized medicine and biohealth technology....
Cellular therapies, such as Chimeric Antigen Receptor (CAR) T-cell therapy and stem cell therapy, are promising new avenues in cancer treatment and regenerative medicine. Many of these therapies are still in their infancy, requiring further development to increase efficacy and accessibility....